Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells in Subjects With Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 31 Dec 2014
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol succinate
- Indications Hypertension
- Focus Pharmacodynamics
- 15 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 09 Jan 2010 New trial record